| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/13/2005 | US20050008644 Potentiation of the immune response |
| 01/13/2005 | US20050008640 Method of treating transplant rejection |
| 01/13/2005 | US20050008638 Anticancer agents; immunomoderator; cytokine, antagonist thereof |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | US20050008635 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/13/2005 | US20050008634 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 01/13/2005 | US20050008633 Chemical and physical modulators of bioavailability of inhaled compositions |
| 01/13/2005 | US20050008631 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 01/13/2005 | US20050008627 Administering tumor necrosis factor directly to lungs; asthma therapy; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050008617 Compositions and methods for delivery of short interfering RNA and short hairpin RNA |
| 01/13/2005 | US20050008616 Multiple sclerosis therapy; selective oxidation of interferon polypeptide |
| 01/13/2005 | US20050008615 Conjugates comprising human IL-18 and substitution mutants thereof |
| 01/13/2005 | US20050008614 Herpes virus; papillomas virus; skin; urogenital systems; topical applying; spray dressing |
| 01/13/2005 | US20050008611 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 01/13/2005 | US20050008602 Oligopeptides for promoting hair growth |
| 01/13/2005 | US20050008580 Hemophilia treatment by inhalation of coagulation factors |
| 01/13/2005 | US20050008573 Diagnosis of tumors; in vivo imaging |
| 01/13/2005 | DE10328251A1 Pharmazeutischer Wirkstoff Active Pharmaceutical Ingredient |
| 01/13/2005 | DE10327518A1 Synthetische Peptidkombinationen und Verfahren zu deren Herstellung Synthetic peptide combinations and methods for their preparation |
| 01/13/2005 | CA2568859A1 Cytokine variant polypeptides |
| 01/13/2005 | CA2542396A1 Fish protein hydrolyzate |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2531240A1 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | CA2531238A1 Polypeptides having binding affinity for her2 |
| 01/13/2005 | CA2531226A1 Ubiquitinated tnf receptor 2 and its uses |
| 01/13/2005 | CA2531136A1 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 01/13/2005 | CA2530866A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | CA2530794A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 01/13/2005 | CA2530490A1 Conditioned matrix compositions for tissue restoration |
| 01/13/2005 | CA2529555A1 Leukocyte internalized peptide-drug conjugates |
| 01/13/2005 | CA2528686A1 Dna-based aptamers for human cathepsin g |
| 01/13/2005 | CA2528134A1 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| 01/13/2005 | CA2522329A1 Inhibitors of coronavirus |
| 01/13/2005 | CA2517684A1 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 01/13/2005 | CA2513213A1 Albumin fusion proteins |
| 01/13/2005 | CA2510653A1 Prna chimera |
| 01/13/2005 | CA2494798A1 Ap1 amine oxidase variants |
| 01/12/2005 | EP1496687A1 Digital camera |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496076A1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
| 01/12/2005 | EP1496065A2 Breast specific genes and proteins |
| 01/12/2005 | EP1495767A1 Immunoadjuvant |
| 01/12/2005 | EP1495766A1 Factor VII activating protease (FSAP) derived polypeptides for the treatment of angiogenesis-related disorders |
| 01/12/2005 | EP1495755A1 Use of citrulline for the manufacture of a medicament in the treatment of intestinal failure |
| 01/12/2005 | EP1495322A2 Heteroclitic analogs and related methods |
| 01/12/2005 | EP1495318A1 Method for detecting ligands and targets in a mixture |
| 01/12/2005 | EP1495141A2 Hiv therapeutic |
| 01/12/2005 | EP1495124A2 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 01/12/2005 | EP1495123A1 Erbb3 based methods and compositions for treating neoplasms |
| 01/12/2005 | EP1495117A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 01/12/2005 | EP1495113A2 Stimulation of nerve cell regeneration |
| 01/12/2005 | EP1495110A1 Recombinant spores |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495052A1 Modified factor viii |
| 01/12/2005 | EP1495051A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 01/12/2005 | EP1495050A1 Novel antagonists of mcp proteins |
| 01/12/2005 | EP1495049A2 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| 01/12/2005 | EP1495048A2 Heterogenenous protein networks crosslinked with silicone-containing links,and methos for producing them |
| 01/12/2005 | EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists |
| 01/12/2005 | EP1495045A1 Cytoplasmic transduction peptides and uses thereof |
| 01/12/2005 | EP1495044A1 Heterocyclic amides with alpha-4 integrin antagonist activity |
| 01/12/2005 | EP1495041A1 RNA INTERFERENCE MEDIATED INHIBITION OF G72 AND D-AMINO ACID OXIDASE (DAAO) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/12/2005 | EP1495006A1 Inhibitors of glycinamide ribonucleotide transformylase |
| 01/12/2005 | EP1494728A2 Tissue defect dressings comprising a keratin network |
| 01/12/2005 | EP1494722A1 Treatment methods for eotaxin mediated inflammatory conditions |
| 01/12/2005 | EP1494717A2 Use of resistin to treat hematopoietic disorders |
| 01/12/2005 | EP1494716A2 Use of substances for treating tumors |
| 01/12/2005 | EP1494715A1 Fp receptor antagonists or pgf2 aplha antagonists for treating menorrhagia |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494709A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1494707A2 Synthetic peptides and dna sequences for treatment of multiple sclerosis |
| 01/12/2005 | EP1494706A2 Antimicrobial polymer conjugates |
| 01/12/2005 | EP1494705A1 A composition and method for killing of tumours |
| 01/12/2005 | EP1494704A1 Glp-1 agonist and cardiovascular complications |
| 01/12/2005 | EP1494703A1 Chemokines mutants having improved oral bioavailability |
| 01/12/2005 | EP1494702A2 Composition for stimulating de novo bone induction |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494700A2 Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents |
| 01/12/2005 | EP1494699A2 Methods for inhibiting vascular hyperpermeability |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494696A2 Treatment of lung disorder |
| 01/12/2005 | EP1494694A2 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1494690A2 Cochleates made with purified soy phosphatidylserine |
| 01/12/2005 | EP1494687A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 01/12/2005 | EP1494665A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 01/12/2005 | EP1494638A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation |
| 01/12/2005 | EP1494614A1 Enzyme disruption of bacterial biofilms |
| 01/12/2005 | EP1494613A2 Potent oncolytic herpes simplex virus for cancer therapy |
| 01/12/2005 | EP1494542A1 Composition for modulating a physiological reaction or inducing an immune response |
| 01/12/2005 | EP1494541A1 Canola protein isolate compositions |
| 01/12/2005 | EP1494539A1 Cheese capable of disinfecting helicobacter pylori |
| 01/12/2005 | EP1494536A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 01/12/2005 | EP1494535A2 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 01/12/2005 | EP1494530A2 Combination therapy using trefoil peptides |
| 01/12/2005 | EP1373499A4 Hin-1, a tumor suppressor gene |
| 01/12/2005 | EP1365781A4 Acrochordon alleviation |
| 01/12/2005 | EP1337548A4 Anti-angiogenic polypeptides |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |